161 related articles for article (PubMed ID: 18930707)
21. Regulation of extra-embryonic endoderm stem cell differentiation by Nodal and Cripto signaling.
Kruithof-de Julio M; Alvarez MJ; Galli A; Chu J; Price SM; Califano A; Shen MM
Development; 2011 Sep; 138(18):3885-95. PubMed ID: 21862554
[TBL] [Abstract][Full Text] [Related]
22. Role of Cripto-1 in stem cell maintenance and malignant progression.
Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
[TBL] [Abstract][Full Text] [Related]
23. The carboxyl terminus of Dictyostelium discoideum protein 1I encodes a functional glycosyl-phosphatidylinositol signal sequence.
Stevens BA; White IJ; Hames BD; Hooper NM
Biochim Biophys Acta; 2001 Apr; 1511(2):317-29. PubMed ID: 11286975
[TBL] [Abstract][Full Text] [Related]
24. Cripto as a target for cancer immunotherapy.
Hu XF; Xing PX
Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
[TBL] [Abstract][Full Text] [Related]
25. Fusion of sequence elements from non-anchored proteins to generate a fully functional signal for glycophosphatidylinositol membrane anchor attachment.
Moran P; Caras IW
J Cell Biol; 1991 Dec; 115(6):1595-600. PubMed ID: 1836788
[TBL] [Abstract][Full Text] [Related]
26. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
[TBL] [Abstract][Full Text] [Related]
27. The endoplasmic reticulum (ER) translocon can differentiate between hydrophobic sequences allowing signals for glycosylphosphatidylinositol anchor addition to be fully translocated into the ER lumen.
Dalley JA; Bulleid NJ
J Biol Chem; 2003 Dec; 278(51):51749-57. PubMed ID: 14530277
[TBL] [Abstract][Full Text] [Related]
28. An internally positioned signal can direct attachment of a glycophospholipid membrane anchor.
Caras IW
J Cell Biol; 1991 Apr; 113(1):77-85. PubMed ID: 1706725
[TBL] [Abstract][Full Text] [Related]
29. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
[TBL] [Abstract][Full Text] [Related]
30. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.
Papageorgiou I; Nicholls PK; Wang F; Lackmann M; Makanji Y; Salamonsen LA; Robertson DM; Harrison CA
Reprod Biol Endocrinol; 2009 Oct; 7():122. PubMed ID: 19874624
[TBL] [Abstract][Full Text] [Related]
31. Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment.
Kodukula K; Gerber LD; Amthauer R; Brink L; Udenfriend S
J Cell Biol; 1993 Feb; 120(3):657-64. PubMed ID: 8425894
[TBL] [Abstract][Full Text] [Related]
32. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
[TBL] [Abstract][Full Text] [Related]
33. Construction of synthetic signals for glycosyl-phosphatidylinositol anchor attachment. Analysis of amino acid sequence requirements for anchoring.
Coyne KE; Crisci A; Lublin DM
J Biol Chem; 1993 Mar; 268(9):6689-93. PubMed ID: 8454641
[TBL] [Abstract][Full Text] [Related]
34. Gaa1p and gpi8p are components of a glycosylphosphatidylinositol (GPI) transamidase that mediates attachment of GPI to proteins.
Ohishi K; Inoue N; Maeda Y; Takeda J; Riezman H; Kinoshita T
Mol Biol Cell; 2000 May; 11(5):1523-33. PubMed ID: 10793132
[TBL] [Abstract][Full Text] [Related]
35. Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
Bianco C; Normanno N; Salomon DS; Ciardiello F
Growth Factors; 2004 Sep; 22(3):133-9. PubMed ID: 15518236
[No Abstract] [Full Text] [Related]
36. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
37. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
[TBL] [Abstract][Full Text] [Related]
38. A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation.
Shen MM; Wang H; Leder P
Development; 1997 Jan; 124(2):429-42. PubMed ID: 9053319
[TBL] [Abstract][Full Text] [Related]
39. A cleavable N-terminal signal peptide is not a prerequisite for the biosynthesis of glycosylphosphatidylinositol-anchored proteins.
Howell S; Lanctôt C; Boileau G; Crine P
J Biol Chem; 1994 Jun; 269(25):16993-6. PubMed ID: 7516327
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1.
Watanabe K; Nagaoka T; Lee JM; Bianco C; Gonzales M; Castro NP; Rangel MC; Sakamoto K; Sun Y; Callahan R; Salomon DS
J Cell Biol; 2009 Nov; 187(3):343-53. PubMed ID: 19948478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
